Literature DB >> 17301807

Age-related differences in leukemia biology and prognosis: the paradigm of MLL-AF4-positive acute lymphoblastic leukemia.

C-H Pui, D Campana.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17301807     DOI： 10.1038/sj.leu.2404598

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  11 in total

1.  Dexamethasone compared to prednisolone for adults with acute lymphoblastic leukemia or lymphoblastic lymphoma: final results of the ALL-4 randomized, phase III trial of the EORTC Leukemia Group.

Authors:  Boris Labar; Stefan Suciu; Roel Willemze; Petra Muus; Jean-Pierre Marie; Georges Fillet; Zwi Berneman; Branimir Jaksic; Walter Feremans; Dominique Bron; Harm Sinnige; Martin Mistrik; Gerard Vreugdenhil; Robrecht De Bock; Damir Nemet; Caroline Gilotay; Sergio Amadori; Theo de Witte
Journal:  Haematologica       Date:  2010-04-07       Impact factor: 9.941

2.  Identification of CD34+ and CD34- leukemia-initiating cells in MLL-rearranged human acute lymphoblastic leukemia.

Authors:  Yuki Aoki; Takashi Watanabe; Yoriko Saito; Yoko Kuroki; Atsushi Hijikata; Masatoshi Takagi; Daisuke Tomizawa; Mariko Eguchi; Minenori Eguchi-Ishimae; Akiko Kaneko; Rintaro Ono; Kaori Sato; Nahoko Suzuki; Saera Fujiki; Katsuyoshi Koh; Eiichi Ishii; Leonard D Shultz; Osamu Ohara; Shuki Mizutani; Fumihiko Ishikawa
Journal:  Blood       Date:  2014-12-23       Impact factor: 22.113

3.  Genetic and clinical characterization of 45 acute leukemia patients with MLL gene rearrangements from a single institution.

Authors:  Nuno Cerveira; Susana Lisboa; Cecília Correia; Susana Bizarro; Joana Santos; Lurdes Torres; Joana Vieira; João D Barros-Silva; Dulcineia Pereira; Cláudia Moreira; Claus Meyer; Tereza Oliva; Ilídia Moreira; Ângelo Martins; Luísa Viterbo; Vítor Costa; Rolf Marschalek; Armando Pinto; José M Mariz; Manuel R Teixeira
Journal:  Mol Oncol       Date:  2012-07-14       Impact factor: 6.603

4.  Advances in the Biology of Acute Lymphoblastic Leukemia-From Genomics to the Clinic.

Authors:  Charles G Mullighan; Cheryl L Willman
Journal:  J Adolesc Young Adult Oncol       Date:  2011-06       Impact factor: 2.223

5.  HOXA9 is required for survival in human MLL-rearranged acute leukemias.

Authors:  Joerg Faber; Andrei V Krivtsov; Matthew C Stubbs; Renee Wright; Tina N Davis; Marry van den Heuvel-Eibrink; Christian M Zwaan; Andrew L Kung; Scott A Armstrong
Journal:  Blood       Date:  2008-12-03       Impact factor: 22.113

Review 6.  Genomic characterization of childhood acute lymphoblastic leukemia.

Authors:  Charles G Mullighan
Journal:  Semin Hematol       Date:  2013-10-04       Impact factor: 3.851

Review 7.  MLL fusions: pathways to leukemia.

Authors:  Han Liu; Emily H Y Cheng; James J D Hsieh
Journal:  Cancer Biol Ther       Date:  2009-07       Impact factor: 4.742

Review 8.  Dysregulation of haematopoietic stem cell regulatory programs in acute myeloid leukaemia.

Authors:  Silvia Basilico; Berthold Göttgens
Journal:  J Mol Med (Berl)       Date:  2017-04-20       Impact factor: 4.599

9.  Influence of pre-transplant minimal residual disease on prognosis after Allo-SCT for patients with acute lymphoblastic leukemia: systematic review and meta-analysis.

Authors:  Zhenglei Shen; Xuezhong Gu; Wenwen Mao; Liefen Yin; Ling Yang; Zhe Zhang; Kunmei Liu; Lilan Wang; Yunchao Huang
Journal:  BMC Cancer       Date:  2018-07-23       Impact factor: 4.430

10.  Dissecting the early steps of MLL induced leukaemogenic transformation using a mouse model of AML.

Authors:  Silvia Basilico; Xiaonan Wang; Alison Kennedy; Konstantinos Tzelepis; George Giotopoulos; Sarah J Kinston; Pedro M Quiros; Kim Wong; David J Adams; Larissa S Carnevalli; Brian J P Huntly; George S Vassiliou; Fernando J Calero-Nieto; Berthold Göttgens
Journal:  Nat Commun       Date:  2020-03-16       Impact factor: 14.919
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.